NewsBenzingaTruist Securities、Tenet Healthcareの「買い」を再確認、目標株価を305ドルに引き上げ Truist Securities、Tenet Healthcareの「買い」を再確認、目標株価を305ドルに引き上げ Benzinga 2026.11.03 17:06 (GMT+0) Open on Benzinga Other news Citigroup Maintains Buy on Madrigal Pharmaceuticals, Raises Price Target to $760 Citigroup Maintains Neutral on LyondellBasell Industries, Raises Price Target to $74 SpaceX Partners With Air Tahiti Nui To Equip Entire Fleet With Free Starlink Wi-Fi 'Meta Draws $58 Billion Demand for US Leg of Cross-Border Bond' - Bloomberg News Citigroup Maintains Neutral on FMC, Raises Price Target to $7 Citigroup Maintains Buy on Eastman Chemical, Lowers Price Target to $75
